These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 25727150)

  • 1. Glycosylation and liver cancer.
    Mehta A; Herrera H; Block T
    Adv Cancer Res; 2015; 126():257-79. PubMed ID: 25727150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients.
    Mondal G; Saroha A; Bose PP; Chatterjee BP
    Glycoconj J; 2016 Apr; 33(2):209-18. PubMed ID: 27034286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma.
    Comunale MA; Lowman M; Long RE; Krakover J; Philip R; Seeholzer S; Evans AA; Hann HW; Block TM; Mehta AS
    J Proteome Res; 2006 Feb; 5(2):308-15. PubMed ID: 16457596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Linked Glycan Branching and Fucosylation Are Increased Directly in Hcc Tissue As Determined through in Situ Glycan Imaging.
    West CA; Wang M; Herrera H; Liang H; Black A; Angel PM; Drake RR; Mehta AS
    J Proteome Res; 2018 Oct; 17(10):3454-3462. PubMed ID: 30110170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein glycosylation in viral hepatitis-related HCC: Characterization of heterogeneity, biological roles, and clinical implications.
    Zhang S; Cao X; Gao Q; Liu Y
    Cancer Lett; 2017 Oct; 406():64-70. PubMed ID: 28789967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma.
    Comunale MA; Rodemich-Betesh L; Hafner J; Wang M; Norton P; Di Bisceglie AM; Block T; Mehta A
    PLoS One; 2010 Aug; 5(8):e12419. PubMed ID: 20811639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating transcriptomics, glycomics and glycoproteomics to characterize hepatitis B virus-associated hepatocellular carcinoma.
    Li Z; Zhang N; Dong Z; Wang X; Zhou J; Gao J; Yang Y; Li J; Guan F; Zhou Y; Tan Z
    Cell Commun Signal; 2024 Apr; 22(1):200. PubMed ID: 38561745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular viral oncology of hepatocellular carcinoma.
    Block TM; Mehta AS; Fimmel CJ; Jordan R
    Oncogene; 2003 Aug; 22(33):5093-107. PubMed ID: 12910247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum profiling based on fucosylated glycoproteins for differentiating between chronic hepatitis B and hepatocellular carcinoma.
    Liao J; Zhang R; Qian H; Cao L; Zhang Y; Xu W; Li J; Wu M; Yin Z
    Biochem Biophys Res Commun; 2012 Apr; 420(2):308-14. PubMed ID: 22425980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosylation characteristics of colorectal cancer.
    Holst S; Wuhrer M; Rombouts Y
    Adv Cancer Res; 2015; 126():203-56. PubMed ID: 25727149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans.
    Block TM; Comunale MA; Lowman M; Steel LF; Romano PR; Fimmel C; Tennant BC; London WT; Evans AA; Blumberg BS; Dwek RA; Mattu TS; Mehta AS
    Proc Natl Acad Sci U S A; 2005 Jan; 102(3):779-84. PubMed ID: 15642945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased levels of tetra-antennary N-linked glycan but not core fucosylation are associated with hepatocellular carcinoma tissue.
    Mehta A; Norton P; Liang H; Comunale MA; Wang M; Rodemich-Betesh L; Koszycki A; Noda K; Miyoshi E; Block T
    Cancer Epidemiol Biomarkers Prev; 2012 Jun; 21(6):925-33. PubMed ID: 22490318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
    Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
    Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct effects of hepatitis B virus-encoded proteins and chronic infection in liver cancer development.
    Ringelhan M; Heikenwalder M; Protzer U
    Dig Dis; 2013; 31(1):138-51. PubMed ID: 23797136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fucosylated glycoproteins as markers of liver disease.
    Mehta A; Block TM
    Dis Markers; 2008; 25(4-5):259-65. PubMed ID: 19126969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass Spectrometric N-Glycan Analysis of Haptoglobin from Patient Serum Samples Using a 96-Well Plate Format.
    Zhu J; Wu J; Yin H; Marrero J; Lubman DM
    J Proteome Res; 2015 Nov; 14(11):4932-9. PubMed ID: 26448449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein expression and fucosylated glycans of the serum haptoglobin-{beta} subunit in hepatitis B virus-based liver diseases.
    Shu H; Zhang S; Kang X; Li S; Qin X; Sun C; Lu H; Liu Y
    Acta Biochim Biophys Sin (Shanghai); 2011 Jul; 43(7):528-34. PubMed ID: 21606158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.